Home > Financial Ratios > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Core EBITDA Growth

    Back to All Ratios
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results

PROCTER & GAMBLE HEALTH Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2026Mar2025Jun2024Jun2023Jun2022
   Core EBITDA Growth(%) 44.192.21-6.2522.156.34

What is the latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH ?

The latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH is 44.19 based on Mar2026 Standalone results.
Year Core EBITDA Growth
Mar202644.19
Mar20252.21
Jun2024-6.25
Jun202322.15
Jun20226.34

How is Core EBITDA Growth of PROCTER & GAMBLE HEALTH Trending?

Years Core EBITDA Growth % Change
Mar2026 44.19
1,899.55
Mar2025 2.21
Positive
Jun2024 -6.25
Negative
Jun2023 22.15
249.37
Jun2022 6.34 -

Other Financial Ratios of PROCTER & GAMBLE HEALTH


Compare Core EBITDA Growth ratio of peers of PROCTER & GAMBLE HEALTH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH ₹8,410.6 Cr -1.8% -8% -18.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,831.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹242,074.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,355.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹107,439.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,417.0 Cr 1.5% 3.1% 0.4% Stock Analytics


PROCTER & GAMBLE HEALTH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH

-1.8%

-8%

-18.1%

SENSEX

0.6%

-1.4%

-10.7%


You may also like the below Video Courses